Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Cerullo

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Human Gene Therapy|February 7, 2009
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia BNicola Brunetti-Pierri, Nathan C Grove, Yu Zuo, et al.
Cancers|February 25, 2023
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based ImmunotherapiesLorella Tripodi, Emanuele Sasso, Sara Feola, et al.
International Journal of Cancer|June 12, 2016
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma modelLukasz Kuryk, Elina Haavisto, Mariangela Garofalo, et al.
The Journal of Gene Medicine|May 5, 2010
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovirIulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2007
Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectorsVincenzo Cerullo, Michael P Seiler, Viraj Mane, et al.
International Journal of Cancer|July 22, 2014
GMCSF-armed vaccinia virus induces an antitumor immune responseSuvi Parviainen, Marko Ahonen, Iulia Diaconu, et al.
Biomacromolecules|November 17, 2022
Mannosylated Polycations Target CD206<sup>+</sup> Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer VaccinationFederica Bellato, Sara Feola, Gloria Dalla Verde, et al.
Cancer Research|July 26, 2014
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumorsNobuhiro Nishio, Iulia Diaconu, Hao Liu, et al.
Molecular Cancer Therapeutics|February 11, 2016
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor ActivityMariangela Garofalo, Barbara Iovine, Lukasz Kuryk, et al.
Acta Biomaterialia|September 10, 2022
Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapyWujun Xu, Cui Pang, Chaojun Song, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Human Gene Therapy|February 7, 2009
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia BNicola Brunetti-Pierri, Nathan C Grove, Yu Zuo, et al.
Cancers|February 25, 2023
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based ImmunotherapiesLorella Tripodi, Emanuele Sasso, Sara Feola, et al.
International Journal of Cancer|June 12, 2016
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma modelLukasz Kuryk, Elina Haavisto, Mariangela Garofalo, et al.
The Journal of Gene Medicine|May 5, 2010
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovirIulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2007
Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectorsVincenzo Cerullo, Michael P Seiler, Viraj Mane, et al.
International Journal of Cancer|July 22, 2014
GMCSF-armed vaccinia virus induces an antitumor immune responseSuvi Parviainen, Marko Ahonen, Iulia Diaconu, et al.
Biomacromolecules|November 17, 2022
Mannosylated Polycations Target CD206<sup>+</sup> Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer VaccinationFederica Bellato, Sara Feola, Gloria Dalla Verde, et al.
Cancer Research|July 26, 2014
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumorsNobuhiro Nishio, Iulia Diaconu, Hao Liu, et al.
Molecular Cancer Therapeutics|February 11, 2016
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor ActivityMariangela Garofalo, Barbara Iovine, Lukasz Kuryk, et al.
Acta Biomaterialia|September 10, 2022
Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapyWujun Xu, Cui Pang, Chaojun Song, et al.
Pageof 14